Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Nelson

Showing results (11-20 of 448) with videos related to

Pageof 45
Sort By:
Nature Reviews. Cancer|December 12, 2003
Unconventional therapy for prostate cancer: good, bad or questionable?Peter S Nelson, Bruce Montgomery
Frontiers in Endocrinology|November 28, 2022
Endocrine and paracrine characteristics of neuroendocrine prostate cancerTarana Arman, Peter S Nelson
Nature Genetics|June 27, 2013
Leveraging the species barrier to advance cancer therapySong Zhao, Peter S Nelson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2012
Molecular pathways: involving microenvironment damage responses in cancer therapy resistanceYu Sun, Peter S Nelson
Cancer Discovery|July 8, 2017
The Path of Most Resistance: Transdifferentiation Underlies Exceptional Nonresponses to Androgen Receptor Pathway Inhibition in Prostate CancerSeema Sinha, Peter S Nelson
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 28, 2012
Cellular senescence and cancer chemotherapy resistanceRyan R Gordon, Peter S Nelson
Current Opinion in Oncology|February 14, 2012
The androgen/androgen receptor axis in prostate cancerEric G Bluemn, Peter S Nelson
JAMA Oncology|November 25, 2020
Prognostic Genomic Biomarkers in Patients With Localized Prostate Cancer: Is Rising Utilization Justified by Evidence?Daniel W Lin, Peter S Nelson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2025
Targeting the Androgen Receptor Pathway in Prostate Cancer: A PROTrACted StruggleMichael D Nyquist, Peter S Nelson
Molecular Cancer Research : MCR|April 22, 2024
Y Chromosome Loss and Implications for OncologyCanan D Dirican, Peter S Nelson
Pageof 45

Showing results (11-20 of 448) with videos related to

Sort By:
Pageof 45
Nature Reviews. Cancer|December 12, 2003
Unconventional therapy for prostate cancer: good, bad or questionable?Peter S Nelson, Bruce Montgomery
Frontiers in Endocrinology|November 28, 2022
Endocrine and paracrine characteristics of neuroendocrine prostate cancerTarana Arman, Peter S Nelson
Nature Genetics|June 27, 2013
Leveraging the species barrier to advance cancer therapySong Zhao, Peter S Nelson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2012
Molecular pathways: involving microenvironment damage responses in cancer therapy resistanceYu Sun, Peter S Nelson
Cancer Discovery|July 8, 2017
The Path of Most Resistance: Transdifferentiation Underlies Exceptional Nonresponses to Androgen Receptor Pathway Inhibition in Prostate CancerSeema Sinha, Peter S Nelson
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 28, 2012
Cellular senescence and cancer chemotherapy resistanceRyan R Gordon, Peter S Nelson
Current Opinion in Oncology|February 14, 2012
The androgen/androgen receptor axis in prostate cancerEric G Bluemn, Peter S Nelson
JAMA Oncology|November 25, 2020
Prognostic Genomic Biomarkers in Patients With Localized Prostate Cancer: Is Rising Utilization Justified by Evidence?Daniel W Lin, Peter S Nelson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2025
Targeting the Androgen Receptor Pathway in Prostate Cancer: A PROTrACted StruggleMichael D Nyquist, Peter S Nelson
Molecular Cancer Research : MCR|April 22, 2024
Y Chromosome Loss and Implications for OncologyCanan D Dirican, Peter S Nelson
Pageof 45